Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Lata Mathew"'
AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections
Autor:
Judith A. Smith, Anjali A. Gaikwad, Lata Mathew, Barbara Rech, Jonathan P. Faro, Joseph A. Lucci, Yu Bai, Randall J. Olsen, Teresa T. Byrd
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo determine the efficacy, safety, and durability of the use of AHCC supplementation for 6 months to support the host immune system to clear high-risk human papillomavirus (HPV) infections. The AHCC supplement is a proprietary, standardized
Externí odkaz:
https://doaj.org/article/2b8088a9a7f440caa94f097563506041
Autor:
Judith A. Smith, Lata Mathew, Anjali Gaikwad, Barbara Rech, Maryam N. Burney, Jonathan P. Faro, Joseph A. Lucci, Yu Bai, Randall J. Olsen, Teresa T. Byrd
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Objective: There is currently no effective medicine or supplement for clearance of high risk- human papillomavirus (HR-HPV) infections. We have taken a systematic approach evaluating the potential use of AHCC supplementation to support clearance of H
Externí odkaz:
https://doaj.org/article/6dd4a321bec54d67910a060fb56a25d5
Autor:
Maryam Burney BS, Lata Mathew BS, Anjali Gaikwad MS, Elizabeth K. Nugent MD, Anneliese O. Gonzalez MD, Judith A. Smith BS, PharmD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Objective: To determine the activity of fucoidan from Undaria pinnatifida (UPF) and Fucus vesiculosus (FVF) when given in combination of chemotherapy drugs using selected human breast or ovarian cancer orthotopic mouse models. Methods: Mice were inoc
Externí odkaz:
https://doaj.org/article/d67993eddaa04a52bfc30dd8b9053a3b
Autor:
Lata Mathew BS, Maryam Burney BS, Anjali Gaikwad MS, Pranavand Nyshadham MS, Elizabeth K. Nugent MD, Anneliese Gonzalez MD, Judith A. Smith PharmD, BCOP, CPHQ, FCCP, FISOPP
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
Objectives: To evaluate potential hepatic metabolism-mediated drug interactions with fucoidan from Undaria pinnatifida (UPF) or Fucus vesiculosus (FVF) and potential growth inhibition activity with either fucoidan alone or with chemotherapy. In vivo
Externí odkaz:
https://doaj.org/article/5a09f0f89383429a92147f225a17ee24
Autor:
Lata Mathew BS, Anjali Gaikwad MS, Anneliese Gonzalez MD, Elizabeth K. Nugent MD, Judith A. Smith PharmD
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
Objective. To determine the impact on antitumor activity when active hexose correlated compound (AHCC) in combination with anticancer hormonal agents in orthotopic mouse models of human estrogen receptor positive breast cancer and evaluate impact of
Externí odkaz:
https://doaj.org/article/25360a2aabb7453dbaccd0a22b6c9630
Autor:
Maryam Burney, Judith A. Smith, Anjali Gaikwad, Elizabeth K. Nugent, Lata Mathew, Anneliese Gonzalez
Publikováno v:
Integrative cancer therapies. 17(3)
Objective: To determine the activity of fucoidan from Undaria pinnatifida (UPF) and Fucus vesiculosus (FVF) when given in combination of chemotherapy drugs using selected human breast or ovarian cancer orthotopic mouse models. Methods: Mice were inoc
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
Integrative Cancer Therapies
Integrative Cancer Therapies
Objective. To determine the impact on antitumor activity when active hexose correlated compound (AHCC) in combination with anticancer hormonal agents in orthotopic mouse models of human estrogen receptor positive breast cancer and evaluate impact of
Publikováno v:
Gynecologic oncology. 144(2)
Autor:
Judith A. Smith, Anneliese Gonzalez, Pranavanand Nyshadham, Maryam Burney, Lata Mathew, Elizabeth K. Nugent, Anjali Gaikwad
Publikováno v:
Integrative Cancer Therapies, Vol. 18 (2019) P. 1534735419876325
Integrative Cancer Therapies
Integrative Cancer Therapies
Objectives: To evaluate potential hepatic metabolism-mediated drug interactions with fucoidan from Undaria pinnatifida (UPF) or Fucus vesiculosus (FVF) and potential growth inhibition activity with either fucoidan alone or with chemotherapy. In vivo
Publikováno v:
Gynecologic oncology. 141(2)
The objective of this study was to evaluate the in vivo growth inhibition activity and tumor distribution of Doxil® compared to Lipodox® as its generic (GLD) in human ovarian cancer orthotopic mouse model.In the efficacy study 50 mice were randomiz